Millipore Sigma Vibrant Logo

532606 5-Lipoxygenase Inhibitor, MK591 - CAS 147030-01-1 - Calbiochem

MK591; MK0591; 5-LOX inhibitor, 5- Lipoxygenase inhibitor, FLAP

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: FLAP Inhibitor, MK591, sodium 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoate, L-686,708, MK-0591

Primary Target: FLAP
View Products on Sigmaaldrich.com
532606
查看价格及供货情况

概述

Replacement Information

重要规格表

CAS #Empirical Formula
147030-01-1C₃₄H₃₄ClN₂NaO₃S

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
5.32606.0001
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 玻璃瓶 5 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell permeable, bioavailable, 2-indolealkanoic acid derived compound that acts as a highly potent and selective inhibitor of leukotriene biosynthesis (IC50 = 3.1 nM in intact human polymorphonuclear leukocytes). Shown to inhibit 5-lipoxygenase (5-LOX) activity in LNCaP prostate cancer cells by high-affinity binding to 5-lipoxygenase activating protein (FLAP; IC50 = 1.6 nM in a FLAP binding assay). Induces apoptosis in LNCaP cells without blocking PI 3 kinase-Akt or ERK activities. Also shown to induce rapid phosphorylation of c-Jun N-terminal Kinase (JNK) and indirectly block PKCε activity. Suppresses the deposition of Ab1-40 and Ab1-42 peptides in Tg2576 mice (~40 mg/kg/day in diet) with concomitant reduction in the levels of presenilin 1, nicastrin, APH-1 and Pen-2, but without affecting notch signaling. Exhibits desirable pharmacokinetic properties with tmax of 3.3 h and t1/2 = ~12 h.

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number532606
      Brand Family Calbiochem®
      SynonymsFLAP Inhibitor, MK591, sodium 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoate, L-686,708, MK-0591
      References
      ReferencesChu, J., et al. 2012. J. Neuroinflamm. 9, 127.
      Sarveswaran, S., et al. 2011. Bioch. Biophy. Acta. 1813, 2108.
      Sarveswaran, S., et al. 2010. Cancer Lett. 291, 167.
      Uematsu, T., et al. 1995. Br. J. Clin. Pharm. 40, 59.
      Product Information
      CAS number147030-01-1
      FormWhite solid
      Hill FormulaC₃₄H₃₄ClN₂NaO₃S
      Chemical formulaC₃₄H₃₄ClN₂NaO₃S
      ReversibleY
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetFLAP
      Primary Target IC<sub>50</sub>3.1 nM
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      5.32606.0001 04055977240948

      Documentation

      5-Lipoxygenase Inhibitor, MK591 - CAS 147030-01-1 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      参考

      参考信息概述
      Chu, J., et al. 2012. J. Neuroinflamm. 9, 127.
      Sarveswaran, S., et al. 2011. Bioch. Biophy. Acta. 1813, 2108.
      Sarveswaran, S., et al. 2010. Cancer Lett. 291, 167.
      Uematsu, T., et al. 1995. Br. J. Clin. Pharm. 40, 59.

      小册子

      标题
      NPI Flyer- Epigenetics and Nuclear Function Feature
      New Products - Antibodies, Small Molecule, Inhibitors

      技术信息

      标题
      White Paper: Further considerations of antibody validation and usage.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision19-December-2014 JSW
      SynonymsFLAP Inhibitor, MK591, sodium 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoate, L-686,708, MK-0591
      DescriptionA cell permeable, bioavailable, 2-indolealkanoic acid derived compound that acts as a highly potent and selective inhibitor of leukotriene biosynthesis (IC50 = 3.1 nM in intact human polymorphonuclear leukocytes). Shown to inhibit 5-lipoxygenase (5-LOX) activity in LNCaP prostate cancer cells by high-affinity binding to 5-lipoxygenase activating protein (FLAP; IC50 = 1.6 nM in a FLAP binding assay). Induces apoptosis in LNCaP cells without blocking PI 3 kinase-Akt or ERK activities. Also shown to induce rapid phosphorylation of c-Jun N-terminal Kinase (JNK) and indirectly block PKCε activity. Suppresses the deposition of Ab1-40 and Ab1-42 peptides in Tg2576 mice (~40 mg/kg/day in diet) with concomitant reduction in the levels of presenilin 1, nicastrin, APH-1 and Pen-2, but without affecting notch signaling. Exhibits desirable pharmacokinetic properties with tmax of 3.3 h and t1/2 = ~12 h.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number147030-01-1
      Chemical formulaC₃₄H₃₄ClN₂NaO₃S
      Purity≥98% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesChu, J., et al. 2012. J. Neuroinflamm. 9, 127.
      Sarveswaran, S., et al. 2011. Bioch. Biophy. Acta. 1813, 2108.
      Sarveswaran, S., et al. 2010. Cancer Lett. 291, 167.
      Uematsu, T., et al. 1995. Br. J. Clin. Pharm. 40, 59.